Journal profile · Pharmacology & Pharmacy
ACTA POLONIAE PHARMACEUTICA
ISSN 0001-6837 · eISSN 2353-5288 · Polish Pharmaceutical Society · POLAND · Quarterly · Founded 1937
ACTA POLONIAE PHARMACEUTICA: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.57; fully open access; APC charged, amount not published; review 6–12 weeks (community reports); community-reported acceptance: easy; 84 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
ACTA POLONIAE PHARMACEUTICA is published by Polish Pharmaceutical Society and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Analytical Methods in Pharmaceuticals, Synthesis and biological activity and Analytical Chemistry and Chromatography, together about 24.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The international journal of the Polish Pharmaceutical Society is published in 6 issues a year. The journal offers Open Access publication of original research papers, short communications and reviews written in English, in all areas of pharmaceutical sciences.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Michał TomczykPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Analytical Methods in PharmaceuticalsChemistry9.9%
- Synthesis and biological activityChemistry8.5%
- Analytical Chemistry and ChromatographyChemistry6.1%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance6.1%
- Computational Drug Discovery MethodsComputer Science5.8%
- Pharmaceutical Practices and Patient OutcomesMedicine4.5%
- Pharmaceutical studies and practicesMedicine4.5%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
iThenticate software (CrossCheck)Publisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.57LetPub ·
- Impact factor (publisher) 2025
- 0.6Publisher website ·
- CiteScore 2026-06
- 0.8LetPub ·
- SJR 2026-06
- 0.19LetPub ·
- SNIP 2026-06
- 0.17LetPub ·
- h-index
- 35LetPub ·
- h-index
- 13OpenAlex ·
- i10-index
- 25OpenAlex ·
- 2-year mean citedness
- 0.4OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 97.79%LetPub ·
Volume
- Articles per year
- 67LetPub ·
Articles by year OpenAlex count · 762 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 52 | 52 | 1 |
| 2025 | 84 | 84 | 10 |
| 2024 | 73 | 73 | 73 |
| 2023 | 105 | 105 | 126 |
| 2022 | 89 | 89 | 140 |
| 2021 | 75 | 75 | 164 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | PLN 4,120 / EUR 950 | No | CC BY-NC | |
| Publisher website | EUR 950 | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- PLN 3,900
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Reference style
- Numbered, in order of citation
- Cover letter
- Required
- Not considered
- supplementary material
Article types accepted4
- original research articleActa Poloniae Pharmaceutica – Drug Research publishes Reviews, Original Research Article as well as Short Communications are also accepted.Length not stated
- reviewsActa Poloniae Pharmaceutica – Drug Research publishes Reviews, Original Research Article as well as Short Communications are also accepted.Length not stated
- short communicationThe same general rules apply like for regular articles, except that an abstract is not required, and the number of figures and/or tables should not be more than…Length not stated
- short communicationsActa Poloniae Pharmaceutica – Drug Research publishes Reviews, Original Research Article as well as Short Communications are also accepted.Length not stated
Policy excerpts from the journal's websiteLicense & copyright, Open access, Peer review, Plagiarism
- License & copyright
Copyright belongs to the publisher upon acceptance Model summary
Copyright belongs to the publisher upon acceptance of the manuscript.
Source ↗Publisher website ·- Open access
Full open access Model summary
All articles published in Acta Poloniae Pharmaceutica – Drug Research (ISSN ) are published in full open access.
Source ↗Publisher website ·- Peer review
Peer review by independent referees Model summary
All contributions are peer-reviewed by independent referees.
Source ↗Publisher website ·- Plagiarism Plagiarism detection
Plagiarism detection using iThenticate (CrossCheck) Model summary
All manuscripts will be checked using the industry standard iThenticate software (CrossCheck). You will receive an annotated report, including advice on parts of the manuscript that should be changed. If there are issues that need to be addressed, authors will be able to revise and resubmit your manuscript before the peer-review process.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Polish Pharmaceutical Society
- Country or region
- POLAND
- Language
- English
- Frequency
- Quarterly
- Founded
- 1937
- ISSN
- 0001-6837
- Electronic ISSN
- 2353-5288
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about ACTA POLONIAE PHARMACEUTICA
What CAS zone is ACTA POLONIAE PHARMACEUTICA in?
In the 2025 upgraded edition of the CAS Journal Ranking, ACTA POLONIAE PHARMACEUTICA is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ACTA POLONIAE PHARMACEUTICA?
The latest impact factor listed by LetPub is 0.57; CiteScore 0.8, h-index 13.
How long does peer review take at ACTA POLONIAE PHARMACEUTICA?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of ACTA POLONIAE PHARMACEUTICA?
According to the journal's author guidelines: Reference style: Numbered, in order of citation; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index ACTA POLONIAE PHARMACEUTICA?
According to LetPub and DOAJ records, ACTA POLONIAE PHARMACEUTICA is indexed in SCIE, Scopus and DOAJ.
Is ACTA POLONIAE PHARMACEUTICA open access, and what is the APC?
ACTA POLONIAE PHARMACEUTICA is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .